Top compounds associated with response to SLC39A1


Feature Type Standardized
Nominal ANOVA
mRNA FH535 GDSC1000 pan-cancer AAC 0.11 0.003
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA RITA CTRPv2 pan-cancer AAC 0.11 0.003
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA AZD8055 GDSC1000 pan-cancer AAC -0.1 0.005
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 0.005
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA QL-XI-92 GDSC1000 pan-cancer AAC -0.093 0.005
mRNA BI-2536 GDSC1000 pan-cancer AAC -0.16 0.005
mRNA Erlotinib gCSI pan-cancer AAC 0.18 0.006
Download CSV